How the interplay between the transcription factor and the chromatin remodeling activity of p53, in a normal cellular context or upon the induction of DNA damage, affects the cell fate and is a question currently awaiting answers; it might have important implications when thinking about cancer therapy. Here, TP53 is linked to cancer.